Healthy Skepticism Library item: 2865
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Painkiller Pushing Up Liver Failure Rate in US
Reuters 2005 Dec 6
http://web.archive.org/web/20051213021219/http://www.nlm.nih.gov/medlineplus/news/fullstory_28487.html
Notes:
Ralph Faggotter’s Comments:
The best way to look at choice of medication is to choose the LEAST HARMFUL medication for a purpose.
It is unlikely that drug advertising will ever be presented in this way unless mandated by law.
Since it became clear that the use of NSAIDS for treating the pain of osteo-arthritis is fraught with dangers, and that COX 2 selective drugs were not going to save the day, the emphasis has been on the use of acetaminophen (paracetamol) for reducing the pain level.
Unfortunatley acetaminophen has its own problems with liver toxicity.
The supporters of acetaminophen would argue that the toxicity is only likely to occur with overdosing, which is true — but that is to gloss over the vagiaries of human behaviour.
People in pain have an understandable tendency to take more of their analgesic medication than the recommended dose.
Acetaminophen/paracetamol should be presented to the public as ‘LESS DANGEROUS’ than non-steroidal anti-inflammatory drugs rather than a ‘SAFE ALTERNATIVE’ as tends to occur at present.
Full text:
Painkiller Pushing Up Liver Failure Rate in US
Reuters Health
Tuesday, December 6, 2005
NEW YORK (Reuters Health) – The percentage of cases of acute liver failure caused by an overdose of acetaminophen increased considerably from 1998 to 2003, with unintentional overdose accounting for at least half of these cases, a new US study shows.
Acetaminophen, known in some countries as paracetamol, is the active ingredient in painkillers like Tylenol. Too much can cause serious liver damage
People with chronic pain, depression and those who abuse substances, including alcohol, may be particularly at risk for unintentional acetaminophen overdose, Dr. Anne M. Larson of the University of Washington in Seattle and colleagues report in the medical journal Hepatology.
“Efforts to limit over-the-counter packaging size and to restrict the prescription of narcotic-acetaminophen combinations (or to separate the narcotic from the acetaminophen) may be necessary to reduce the incidence of this increasingly recognized but preventable cause of acute liver failure in the United States,” Larson and her team write.
The researchers analyzed data on 662 consecutive patients treated for acute liver failure at 22 US tertiary care centers between 1998 and 2003. During that time, the annual percentage of acute liver failure cases due to acetaminophen rose from 28 percent to 51 percent.
Among the 275 cases determined to be acetaminophen-related, 48 percent were unintentional overdoses, 44 percent were suicide attempts, and intent was unknown in 8 percent. Many characteristics of the unintentional and intentional overdose groups were similar, while their clinical outcomes were not different.
Patients who unintentionally overdosed were older than those who attempted suicide, more likely to use several products containing acetaminophen and took longer to seek care after symptoms developed. Seventy-nine percent reported taking the medications for pain.
Depression was reported by 24 percent who unintentionally overdosed, compared with 45 percent of patients who intentionally overdosed.
“Overall, 178 subjects (65 percent) survived, 74 (27 percent) died without transplantation, and 23 subjects (8%) underwent liver transplantation,” Larson’s group found.
The investigators say there is a relatively narrow range between an effective dose of acetaminophen and a dangerous dose. They say that “consistent use of as little as 7.5 grams per day may be hazardous.” One extra-strength Tylenol tablet contains half a gram of acetaminophen.
In an editorial accompanying the study, Dr. John G. O’Grady of King’s College Hospital in London points out that a 1998 rule in the UK restricting over-the-counter sales of acetaminophen to 16 grams led to a 30 percent reduction in hospital admissions for cute liver failure related to the drug, and France’s rule limiting sales to 8 grams has also been effective.
“The required judgment from society, the medical profession, and other interested parties, is whether that level of restriction is too high a price to pay,” he concludes.
SOURCE: Hepatology, December 2005.
Copyright 2005 Reuters. Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. Reuters, the Reuters Dotted Logo and the Sphere Logo are registered trademarks of the Reuters group of companies around the world.
